Skip to main content
Log in

Reduction of menopausal hot flushes by methyldopa

A double blind crossover trial

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

In a double-blind study, methyldopa was shown to be significantly more effective than placebo in reducing menopausal hot flushes. The median reduction in the number of hot flushes was 38% with placebo and 65% with methyldopa. The active metabolite of methyldopa, alpha-methylnoradrenaline, is an alpha2-adrenoceptor agonist. Since the alpha2-adrenoceptor agonist clonidine also reduces hot flushes, while the alpha2-adrenoceptor antagonist yohimbine produces flushes, it is speculated that menopausal hot flushes might result from a reduced stimulation of alpha2-adrenoceptors, probably in the CNS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hutton JD, Murray MAF, Jacobs HS, James VHT (1978) Relation between plasma oestrone and oestradiol and climacteric symptoms. Lancet 1: 678–681

    Google Scholar 

  2. Clayden JR, Bell JW, Pollard P (1974) Menopausal flushing: Double-blind trial of a non-hormonal medication. Br Med J 1: 409–412

    Google Scholar 

  3. Starke K, Endo T (1976) Presynaptic α-adrenoceptors. Gen Pharmacol 7: 307–312

    Google Scholar 

  4. Starke K, Borowski E, Endo T (1975) Preferential blockade of presynaptic α-adrenoceptors by yohimbine. Eur J Pharmacol 34: 385–388

    Google Scholar 

  5. Garfield SL, Gershon S, Sletten I, Sundland D, Ballon S (1967) Chemically induced anxiety. Int J Neuropsychiatry 3: 426–433

    Google Scholar 

  6. Coope J, Thomson JM, Poller L (1975) Effects of “natural oestrogen” replacement therapy on menopausal symptoms and blood clotting. Br Med J 4: 139–143

    Google Scholar 

  7. Baumgardner SB, Condrea H, Daane TA et al (1978) Replacement estrogen therapy for menopausal vasomotor flushes. Obstet Gynaecol 51: 445–452

    Google Scholar 

  8. Coope J, Williams S, Patterson JS (1978) A study of the effectiveness of propranolol in menopausal hot flushes. Br J Obstet Gynaecol 85: 472–475

    Google Scholar 

  9. Heritage AS, Stumpf WE, Sar M, Grant LD (1980) Brainstem catecholamine neurons are target sites for sex steroid hormones. Science 207: 1377–1379

    Google Scholar 

  10. Fishman J, Norton B (1975) Catechol estrogen formation in the central nervous system of the rat. Endocrinology 96: 1054–1059

    Google Scholar 

  11. Ball P, Knuppen R, Haupt M et al. (1972) Interactions between estrogens and catecholamines. J Clin Endocrinol 34: 736–746

    Google Scholar 

  12. Lloyd T, Weisz J, Breakfield XO (1978) The catechol estrogen, 2-hydroxyestradiol, inhibits catechol-O-methyltransferase activity in neuroblastoma cells. J Neurochem 31: 245–250

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nesheim, B.I., Sætre, T. Reduction of menopausal hot flushes by methyldopa. Eur J Clin Pharmacol 20, 413–416 (1981). https://doi.org/10.1007/BF00542092

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00542092

Key words

Navigation